Literature DB >> 8103345

Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine.

A N Chakrabarty1, C P Bhattacharya, S G Dastidar.   

Abstract

Methdilazine (Md) could inhibit various Mycobacterium spp. at 5-15 micrograms/ml concentrations in vitro as well as in vivo. When Md was tested in combination with streptomycin (Sm), rifampicin (Rf) or methyl-DOPA (m-D), it showed synergistic effects only with respect to methyl-DOPA.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8103345     DOI： 10.1111/j.1699-0463.1993.tb00133.x

Source DB:  PubMed          Journal:  APMIS        ISSN： 0903-4641            Impact factor:   3.205


  3 in total

1.  Biotransformation of chlorpromazine and methdilazine by Cunninghamella elegans.

Authors:  D Zhang; J P Freeman; J B Sutherland; A E Walker; Y Yang; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792

Review 2.  A Double-Edged Sword: Thioxanthenes Act on Both the Mind and the Microbiome.

Authors:  Marianne Ø Poulsen; Sujata G Dastidar; Debalina Sinha Roy; Shauroseni Palchoudhuri; Jette Elisabeth H Kristiansen; Stephen J Fey
Journal:  Molecules       Date:  2021-12-29       Impact factor: 4.411

3.  In vitro antibacterial activity of some antihistaminics belonging to different groups against multi-drug resistant clinical isolates.

Authors:  Moustafa A El-Nakeeb; Hamida M Abou-Shleib; Amal M Khalil; Hoda G Omar; Omar M El-Halfawy
Journal:  Braz J Microbiol       Date:  2011-09-01       Impact factor: 2.476
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.